Oct
2026
Fiera Milano, Italy
Visit us
stand 14K15, Finished Dosage & Formulation & stand 14K23, Finished Dosage & Formulation
Zone

Helm AG

Exhibitor at CPHI Milan 2026
About Us

HELM Pharma is a Hamburg based company, passionate about supporting the local pharma, food, and feed industries with high-quality products.

Our portfolio solutions – Finished Dosage Forms and Ingredients & Materials – are fueled by our partnerships.

At HELM we stand as your reliable ally to "Invent Success. Every Day", as we are inspired by making our customers and partners successful, constantly.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2020
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Licensee
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 14K15, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • ENZALUTAMIDE

    Product ENZALUTAMIDE

    40 and 80 mg tablets | Therapeutic use: Prostate Cancer | ATC: L02BB04
  • GLYCOPYRRONIUM + INDACATEROL

    Product GLYCOPYRRONIUM + INDACATEROL

    50 µg + 110 µg capsules dry powder inhaler | Therapeutic use: Chronic obstructive pulmonary disease (COPD) | ATC: R03AL04 

  • ISOCONAZOLE + DIFLUCORTOLONE

    Product ISOCONAZOLE + DIFLUCORTOLONE

    1% - 0.1% cream | Therapeutic use: Skin fungal infections with inflammation | ATC: D01AC20 
  • IVACAFTOR

    Product IVACAFTOR

    150mg film-coated tablets | Therapeutic use: Cystic fibrosis | ATC: R07AX02
  • LIOTHYRONINE ORAL SOLUTION

    Product LIOTHYRONINE ORAL SOLUTION

    10 µg/ml oral solution | Therapeutic use: Treatment of coma of myxedema; Management of severe chronic thyroid deficiency and hypothyroid states occurring in the treatment of thyrotoxicosis | ATC: H03AA02 

Helm AG Resources (1)